Middle East And Africa Pulmonary Function Testing Market
حجم السوق بالمليار دولار أمريكي
CAGR :
% 
 فترة التنبؤ |
2024 –2031 |
 حجم السوق (السنة الأساسية) |
USD 165.48 Million |
 حجم السوق (سنة التنبؤ) |
USD 227.33 Million |
 CAGR |
% |
| Major Markets Players |
سوق اختبار وظائف الرئة في الشرق الأوسط وأفريقيا، حسب النوع (الأجهزة والخدمات والبرامج)، نوع المريض (الأطفال والبالغين وكبار السن)، التطبيق (مرض الانسداد الرئوي ومرض الرئة التقييدي)، المستخدم النهائي (المستشفيات والعيادات المتخصصة ومختبرات التشخيص وإعدادات الرعاية المنزلية وغيرها) - اتجاهات الصناعة والتوقعات حتى عام 2031.
تحليل ورؤى حول سوق اختبار وظائف الرئة في الشرق الأوسط وأفريقيا
إن سوق اختبار وظائف الرئة مدفوع بالانتشار المتزايد لأمراض الجهاز التنفسي والتقدم التكنولوجي والطلب المتزايد على الطب الشخصي. تشمل الاتجاهات الرئيسية في السوق التبني المتزايد لأجهزة اختبار وظائف الرئة في نقطة الرعاية، والطلب المتزايد على أجهزة اختبار وظائف الرئة اللاسلكية والمحمولة، والتركيز المتزايد على الطب الشخصي والطب الدقيق . ومع ذلك، يواجه السوق أيضًا تحديات مثل إمكانية الوصول المحدودة إلى أجهزة اختبار وظائف الرئة في بعض المناطق، والتكلفة العالية لأجهزة اختبار وظائف الرئة والمواد الاستهلاكية، وتعقيد تفسير وتحليل اختبار وظائف الرئة، والوعي المحدود باختبار وظائف الرئة بين مقدمي الرعاية الصحية والمرضى.
تحلل شركة Data Bridge Market Research أن سوق اختبار وظائف الرئة في الشرق الأوسط وأفريقيا من المتوقع أن يصل إلى 227.33 مليون دولار أمريكي بحلول عام 2031 من 165.48 مليون دولار أمريكي في عام 2023، بمعدل نمو سنوي مركب قدره 4.1٪ في الفترة المتوقعة من 2024 إلى 2031.
|
تقرير القياس |
تفاصيل |
|
فترة التنبؤ |
2024 إلى 2031 |
|
سنة الأساس |
2023 |
|
سنوات تاريخية |
2022 (قابلة للتخصيص للفترة 2016-2021) |
|
وحدات كمية |
الإيرادات بالملايين من الدولارات الأمريكية |
|
القطاعات المغطاة |
النوع (الأجهزة والخدمات والبرامج)، نوع المريض (الأطفال والبالغين وكبار السن)، التطبيق (مرض الانسداد الرئوي ومرض الرئة التقييدي)، المستخدم النهائي (المستشفى والعيادات المتخصصة ومختبرات التشخيص وإعدادات الرعاية المنزلية وغيرها) |
|
الدول المغطاة |
المملكة العربية السعودية، الإمارات العربية المتحدة، جنوب أفريقيا، قطر، الكويت، عمان، البحرين، مصر، إسرائيل وبقية دول الشرق الأوسط وأفريقيا |
|
الجهات الفاعلة في السوق المشمولة |
Teleflex Incorporated، وCAIRE, Inc.، وCOSMED srl، وECO MEDICS، وClarity Medical، وData Sciences International، وIngMar Medical، وMEDLINE، وRecorders and Medicare Systems وغيرها |
تعريف السوق
اختبار وظائف الرئة (PFT) هو تقييم شامل لوظائف الرئة، ويُستخدم لتشخيص ومراقبة أمراض الجهاز التنفسي مثل مرض الانسداد الرئوي المزمن (COPD) والربو والتهاب الشعب الهوائية المزمن . يتضمن تعريف السوق لاختبار وظائف الرئة مجموعة من الاختبارات، بما في ذلك السعة الحيوية القسرية (FVC) وحجم الزفير القسري (FEV1) ونسبة FEV1/FVC والتهوية الطوعية القصوى (MVV) وسعة الانتشار (DLCO). يتم إجراء اختبار وظائف الرئة عادةً باستخدام مقياس التنفس، وهو جهاز يقيس حجم وتدفق الهواء الذي يستنشقه المريض وزفيره.
ديناميكيات سوق اختبار وظائف الرئة في الشرق الأوسط وأفريقيا
يتناول هذا القسم فهم محركات السوق والفرص والقيود والتحديات. وسيتم مناقشة كل هذا بالتفصيل أدناه:
السائقين
- تزايد انتشار أمراض الجهاز التنفسي
إن الانتشار المتزايد لأمراض الجهاز التنفسي هو محرك مهم لسوق اختبار وظائف الرئة العالمي. أصبحت حالات مثل مرض الانسداد الرئوي المزمن والربو أكثر شيوعًا بسبب عوامل مثل الشيخوخة السكانية والملوثات البيئية وتغيرات نمط الحياة. مع نمو انتشار هذه الأمراض، هناك طلب متزايد على أدوات تشخيص دقيقة وموثوقة لإدارة ومراقبة هذه الحالات. تعد اختبارات وظائف الرئة ضرورية لتشخيص أمراض الجهاز التنفسي وتقييم شدتها وتتبع تقدم المرض. هذه الحاجة المتزايدة للاختبار المنتظم والدقيق تدفع السوق، حيث يسعى مقدمو الرعاية الصحية والمرضى إلى تقنيات PFT المتقدمة لتحسين نتائج صحة الجهاز التنفسي وتوفير استراتيجيات إدارة فعالة.
- الكشف المبكر عن أمراض الجهاز التنفسي
إن زيادة اضطرابات الجهاز التنفسي التي تتطلب الكشف المبكر عنها تشكل محركًا رئيسيًا لسوق اختبار وظائف الرئة العالمي. إن الارتفاع في اضطرابات الجهاز التنفسي مثل الربو ومرض الانسداد الرئوي المزمن والتليف الكيسي يغذي الطلب على اختبار وظائف الرئة. تلعب اختبارات وظائف الرئة دورًا حاسمًا في تمكين الكشف المبكر والإدارة الفعالة لحالات الجهاز التنفسي، وبالتالي تحسين نتائج المرضى ونوعية الحياة من خلال التدخل والعلاج في الوقت المناسب.
فرصة
- التقدم التكنولوجي السريع
إن تطوير أجهزة اختبار وظائف الرئة المبتكرة، وخاصة تلك المدمجة مع الذكاء الاصطناعي، يعزز دقة التشخيص وكفاءته، مما يوفر نتائج أكثر موثوقية في تحديد أمراض الرئة. أصبحت أنظمة الاختبار الشاملة أكثر سهولة في الاستخدام وقابلة للنقل، مما يجعلها في متناول مجموعة أوسع من إعدادات الرعاية الصحية. يسمح التكامل مع تقنيات الصحة الرقمية، مثل الذكاء الاصطناعي والطب عن بعد، بدقة تشخيصية متقدمة وتحليلات تنبؤية، بالإضافة إلى المراقبة عن بعد من خلال أجهزة اختبار وظائف الرئة المتصلة، مما يوسع نطاق وتأثير هذه الأدوات. توفر تقنيات الاستشعار المتقدمة، بما في ذلك أجهزة الاستشعار عالية الحساسية والقابلة للارتداء، مراقبة مستمرة وجمع البيانات في الوقت الفعلي، مما يتيح تدخلات أكثر دقة وفي الوقت المناسب.
التحديات/ القيود
- ارتفاع تكلفة معدات الاختبار
The high cost of pulmonary function testing equipment hampers market growth by restricting access for smaller healthcare facilities and hindering penetration in certain regions. The substantial investment required for purchasing and maintaining sophisticated PFT devices poses financial challenges for healthcare facilities, particularly in developing regions. This economic barrier restricts the widespread adoption and use of PFT technologies, affecting overall market growth and accessibility. Addressing these cost challenges is essential for enhancing the reach and impact of pulmonary function testing worldwide.
- Lack of Standardization and Variability in Test Results
A notable lack of uniform standards leads to variability in device specifications and test protocols, which can hinder the consistency and comparability of test results across different equipment. This variability complicates efforts to integrate PFT devices with Electronic Health Record (EHR) systems, making seamless data exchange and comprehensive patient records more difficult to achieve. Without standardized protocols, ensuring that data from various PFT devices can be accurately and efficiently integrated into EHR systems remains a complex task.
Recent Developmevnts
- In April 2024, Clario's acquisition of ArtiQ enhances its Respiratory Solutions portfolio by integrating advanced AI capabilities. This strategic move combines Clario's expertise with ArtiQ’s innovative technology to improve test quality and accelerate data processing in clinical trials. The acquisition, alongside Inofab Health, solidifies Clario's leadership in respiratory care and broadens its AI-driven clinical solutions
- In September 2023, PulmOne has launched the MiniBox+ in China, showcasing it to pulmonologists at the 2023 Annual Congress of the Chinese Thoracic Society (CTS) through our distributor HTDK. The introduction was met with great enthusiasm from attendees. Check out the exciting video highlights from the event
- In May 2023, Geratherm Medical AG, was honored as a "hidden champion" by the State Development Corporation of Thuringia (LEG). The recognition highlights the company's significant role in medical technology and its global market presence. Board member Christian Frick expressed gratitude for the accolade, noting the company's innovation in medical diagnostics, lung function measurement, stroke prevention, and incubator systems, which positions it well for future growth
- In May 2023, Vitalograph, a leader in respiratory diagnostics, has expanded its portfolio with the introduction of the Vitalograph tremoflo C-100 Oscillometer at the ATS International Conference. Developed in partnership with Thorasys, this innovative device detects small airway impairment through simple tidal breathing, enhancing the diagnosis of asthma and COPD. The tremoflo C-100 integrates with the Vitalograph Spirotrac platform, offering a comprehensive view of respiratory health and supporting accurate, portable testing in various settings
- In April 2023, Ingmar Medical introduced RespiSim Software Version 4.3 a key advancement, including improved scenario import/export, reduced simulation lag, and enhanced platform stability. These updates significantly elevate usability and performance, making it a vital tool for respiratory therapy education and training
- In September 2022, IngMar Medical launches RespiSim eLearning, a subscription-based platform providing affordable, realistic ventilation training. Featuring a Virtual Ventilator and a suite of Cleveland Clinic courses, this new offering supports hybrid and remote education, fostering a community of educators dedicated to enhancing patient outcomes
Middle East and Africa Pulmonary Function Testing Market Scope
The Middle East and Africa pulmonary function testing market is segmented into four notable segments based on type, patient type, application, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Type
- Hardware
- Software
- Services
On the basis of service, the Middle East and Africa pulmonary function testing market is segmented into hardware, software, and services.
Patient Type
- Adult
- Geriatric
- Pediatric
On the basis of patient type, the Middle East and Africa pulmonary function testing market is segmented into adult, geriatric, and pediatric.
Application
- Obstructive Lung Disease
- Restrictive Lung Disease
On the basis of application, the Middle East and Africa pulmonary function testing market is segmented into obstructive lung disease and restrictive lung disease.
End User
- Hospital
- Specialty Clinics
- Diagnostics Laboratories
- Home Care Settings
- Others
On the basis of end user, the Middle East and Africa pulmonary function testing market is segmented into hospital, specialty clinics, diagnostics laboratories, home care settings, and others.
Middle East and Africa Pulmonary Function Testing Market Regional Analysis/Insights
The Middle East and Africa pulmonary function testing market is segmented into four notable segments based on type, patient type, application, and end user.
The countries covered in this market report are Saudi Arabia, U.A.E., South Africa, Qatar, Kuwait, Oman, Bahrain, Egypt, Israel and rest of Middle East and Africa.
من المتوقع أن تهيمن جنوب إفريقيا على منطقة الشرق الأوسط وأفريقيا بسبب وجود اللاعبين في السوق وتحسين التطوير والبحث في قطاع الرعاية الصحية. يساهم التبني المبكر للتكنولوجيا في المنطقة والسوق الناضجة في الطلب القوي على الحلول المتقدمة.
كما يوفر قسم الدولة في التقرير عوامل فردية مؤثرة على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. تعد نقاط البيانات مثل المبيعات الجديدة ومبيعات الاستبدال والتركيبة السكانية للدولة والقوانين التنظيمية ورسوم الاستيراد والتصدير من بين المؤشرات الرئيسية المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر شركات الخدمات الكبيرة والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من اللاعبين المحليين والمحليين وتأثير قنوات المبيعات أثناء تقديم تحليل توقعات لبيانات الدولة.
تحليل المنافسة وحصة سوق اختبار وظائف الرئة في الشرق الأوسط وأفريقيا
يقدم المشهد التنافسي لسوق اختبار وظائف الرئة في الشرق الأوسط وأفريقيا تفاصيل عن المنافسين. تتضمن التفاصيل نظرة عامة على الشركة، والبيانات المالية للشركة، والإيرادات المولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، ومواقع الإنتاج والمرافق، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وموافقات المنتج، وعرض المنتج ونطاقه، وهيمنة التطبيق، ومنحنى خط حياة نوع المنتج. تتعلق نقاط البيانات المذكورة أعلاه فقط بتركيز الشركة على السوق.
اللاعبون الرئيسيون العاملون في السوق هم Teleflex Incorporated و CAIRE، Inc. و COSMED srl و ECO MEDICS و Clarity Medical و Data Sciences International و IngMar Medical و MEDLINE و Recorders and Medicare Systems وغيرها.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF RESPIRATORY DISEASES
6.1.2 EARLY DETECTION OF RESPIRATORY DISEASES
6.1.3 GROWING GERIATRIC POPULATION
6.1.4 INCREASING PRODUCT LAUNCHES AND EMERGENCE OF HOME TESTING DEVICES
6.2 RESTRAINTS
6.2.1 HIGH COST OF TESTING EQUIPMENT
6.2.2 TECHNOLOGICAL LIMITATION OF TESTING DEVICES
6.3 OPPORTUNITIES
6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING STRATEGIC INITIATIVES
6.3.3 GOVERNMENT INITIATIVES AND REIMBURSEMENT POLICIES
6.3.4 PRODUCT DEVELOPMENT FOR AT-HOME TESTING
6.4 CHALLENGES
6.4.1 LACK OF STANDARDIZATION AND VARIABILITY IN TEST RESULTS
6.4.2 LACK OF SKILLED PROFESSIONALS
7 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE
7.1 OVERVIEW
7.2 HARDWARE
7.2.1 PFT DEVICES
7.2.2 PFT ACCESSORIES & CONSUMABLES
7.2.2.1 Spirometry
7.2.2.2 Lung Volume in Unit/ Plethysmography Test
7.2.2.3 Gas Exchange Testing
7.2.2.4 Cardiopulmonary Exercise Test (CPET)
7.2.2.5 Pulse Oximetry Test
7.2.2.6 Diffusion Capacity Test
7.2.2.7 Maximal Voluntary Ventilation
7.2.2.8 Oxygen Titration Test
7.2.2.9 Respiratory Muscle Function
7.2.2.10 Bronchial Provocation Test
7.2.2.11 High Altitude Simulation Testing
7.2.3 OTHERS
7.2.3.1 3.2. Direct Tender
7.2.3.2 3.2. Retail Sales
7.2.4 OTHERS
7.3 SOFTWARE
7.4 SERVICES
8 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE
8.1 OVERVIEW
8.2 ADULT
8.2.1 MALE
8.2.2 FEMALE
8.3 GERIATRIC
8.3.1 MALE
8.3.2 FEMALE
8.4 PEDIATRIC
8.4.1 MALE
8.4.2 FEMALE
9 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 OBSTRUCTIVE LUNG DISEASE
9.2.1 ASTHMA
9.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
9.2.3 BRONCHIECTASIS
9.2.4 CYSTIC FIBROSIS
9.3 RESTRICTIVE LUNG DISEASE
9.3.1 LUNG CANCER
9.3.2 INTERSTITIAL LUNG DISEASE
9.3.3 AMYOTROPHIC LATERAL SCLEROSIS (ALS)
9.3.4 SCOLIOSIS
9.3.5 SARCOIDOSIS
9.3.6 MUSCULAR DYSTROPHY
10 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 PUBLIC
10.2.2 PRIVATE
10.3 SPECIALTY CLINICS
10.4 DIAGNOSTICS LABORATORIES
10.5 HOME CARE SETTINGS
10.6 OTHERS
11 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY REGION
11.1 MIDDLE EAST AND AFRICA
11.1.1 SOUTH AFRICA
11.1.2 SAUDI ARABIA
11.1.3 U.A.E.
11.1.4 ISRAEL
11.1.5 QATAR
11.1.6 KUWAIT
11.1.7 EGYPT
11.1.8 OMAN
11.1.9 BAHRAIN
11.1.10 REST OF MIDDLE EAST AND AFRICA
12 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 VYAIRE MEDICAL, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 COMPANY SHARE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 TELEFLEX INCORPORATED
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO 218
14.2.5 RECENT DEVELOPMENT 218
14.3 CAIRE INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 COMPANY SHARE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 COSMED SRL
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 SCHILLER AG
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 CHEST M.I., INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 CLARITY MEDICAL
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 CONTEC MEDICAL SYSTEMS CO., LTD
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 DATA SCIENCES INTERNATIONAL.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ECO MEDICS
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 FUKUDA SANGYO CO., LTD.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 GANSHORN MEDIZIN ELECTRONIC GMBH
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 GERATHERM MEDICAL AG
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.14 INGMAR MEDICAL
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 INOFAB HEALTH (A CLARIO COMPANY)
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 JK MEDICAL SYSTEMS PVT LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 KOKO, PFT
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 MEC
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 MEDICAL EQUIPMENT EUROPE GMBH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MEDLINE
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 MORGAN SCIENTIFIC
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENTS
14.22 NDD MEDICAL TECHNOLOGIES
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENTS
14.23 PULMONE ADVANCED MEDICAL DEVICES
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.24 RECORDERS & MEDICARE SYSTEMS PRIVATE LIMITED
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 SCIREQ
14.25.1 COMPANY SNAPSHOT
14.25.2 PRODUCT PORTFOLIO
14.25.3 RECENT DEVELOPMENT
14.26 SIBEL, S.A.U
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENT
14.27 VITALOGRAPH
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST AND AFRICA DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 2 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 3 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)
TABLE 6 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 7 MIDDLE EAST AND AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 MIDDLE EAST AND AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)
TABLE 9 MIDDLE EAST AND AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 10 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 11 MIDDLE EAST AND AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 13 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 15 MIDDLE EAST AND AFRICA SOFTWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 16 MIDDLE EAST AND AFRICA SERVICES IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 20 MIDDLE EAST AND AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 MIDDLE EAST AND AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 22 MIDDLE EAST AND AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 23 MIDDLE EAST AND AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 24 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 25 MIDDLE EAST AND AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 26 MIDDLE EAST AND AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 27 MIDDLE EAST AND AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 MIDDLE EAST AND AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 29 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 30 MIDDLE EAST AND AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 MIDDLE EAST AND AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 32 MIDDLE EAST AND AFRICA SPECIALTY CLINICS IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 MIDDLE EAST AND AFRICA DIAGNOSTICS LABORATORIES IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 MIDDLE EAST AND AFRICA HOME CARE SETTINGS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 35 MIDDLE EAST AND AFRICA OTHERS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 37 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 38 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 40 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 41 MIDDLE EAST AND AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 42 MIDDLE EAST AND AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 43 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 44 MIDDLE EAST AND AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 45 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 46 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 47 MIDDLE EAST AND AFRICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 48 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 49 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 50 MIDDLE EAST AND AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 51 MIDDLE EAST AND AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 52 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 53 MIDDLE EAST AND AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 54 MIDDLE EAST AND AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 56 MIDDLE EAST AND AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 SOUTH AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 SOUTH AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 61 SOUTH AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 SOUTH AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 SOUTH AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 64 SOUTH AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 65 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 66 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 67 SOUTH AFRICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 68 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 SOUTH AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 70 SOUTH AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 71 SOUTH AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 72 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 73 SOUTH AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 SOUTH AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 76 SOUTH AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 77 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 79 SAUDI ARABIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 SAUDI ARABIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 81 SAUDI ARABIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 SAUDI ARABIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 SAUDI ARABIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 84 SAUDI ARABIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 87 SAUDI ARABIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 88 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 89 SAUDI ARABIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 90 SAUDI ARABIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 91 SAUDI ARABIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 92 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 93 SAUDI ARABIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 SAUDI ARABIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 96 SAUDI ARABIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 U.A.E. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 100 U.A.E. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 101 U.A.E. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 102 U.A.E. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 103 U.A.E. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 104 U.A.E. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 105 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 107 U.A.E. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 U.A.E. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 110 U.A.E. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 111 U.A.E. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 112 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 113 U.A.E. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 114 U.A.E. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 115 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 116 U.A.E. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 117 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 ISRAEL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 ISRAEL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 121 ISRAEL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 ISRAEL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 ISRAEL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 124 ISRAEL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 125 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 126 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 127 ISRAEL RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 129 ISRAEL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 130 ISRAEL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 131 ISRAEL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 132 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 133 ISRAEL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 ISRAEL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 136 ISRAEL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 QATAR PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 138 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 139 QATAR PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 QATAR PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 141 QATAR PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 QATAR MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 143 QATAR ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 144 QATAR NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 146 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 147 QATAR RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 148 QATAR PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 QATAR ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 150 QATAR GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 151 QATAR PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 152 QATAR PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 153 QATAR OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 QATAR RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 QATAR PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 156 QATAR HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 KUWAIT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 160 KUWAIT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 161 KUWAIT PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 162 KUWAIT MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 163 KUWAIT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 164 KUWAIT NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 166 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 167 KUWAIT RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 KUWAIT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 170 KUWAIT GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 171 KUWAIT PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 172 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 173 KUWAIT OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 174 KUWAIT RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 175 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 176 KUWAIT HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 EGYPT PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 EGYPT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 EGYPT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 181 EGYPT PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 EGYPT MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 EGYPT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 184 EGYPT NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 186 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 187 EGYPT RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 188 EGYPT PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 189 EGYPT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 190 EGYPT GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 191 EGYPT PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 192 EGYPT PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 193 EGYPT OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 194 EGYPT RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 EGYPT PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 196 EGYPT HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 197 OMAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 198 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 OMAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 200 OMAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 201 OMAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 202 OMAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 OMAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 204 OMAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 205 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 206 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 207 OMAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 208 OMAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 209 OMAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 210 OMAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 211 OMAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 212 OMAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 213 OMAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 214 OMAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 215 OMAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 216 OMAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 218 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 219 BAHRAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 220 BAHRAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 221 BAHRAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 222 BAHRAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 223 BAHRAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 224 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 225 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 226 BAHRAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 227 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 228 BAHRAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 229 BAHRAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 230 BAHRAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 231 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 232 BAHRAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 233 BAHRAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 234 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 235 BAHRAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 236 REST OF MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
List of Figure
FIGURE 1 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: SEGMENTATION
FIGURE 11 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES IS DRIVING THE GROWTH OF THE MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET FROM 2024 TO 2031
FIGURE 15 THE HARDWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2023
FIGURE 18 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 20 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2023
FIGURE 22 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 23 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, CAGR (2024-2031)
FIGURE 24 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 25 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY APPLICATION 2023
FIGURE 26 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 27 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY END USER 2023
FIGURE 30 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 31 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: END USER, CAGR (2024-2031)
FIGURE 32 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: END USER, LIFELINE CURVE
FIGURE 33 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: SNAPSHOT (2023)
FIGURE 34 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
